SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-073294
Filing Date
2024-03-21
Accepted
2024-03-21 07:12:59
Documents
15
Period of Report
2024-03-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d717290d8k.htm   iXBRL 8-K 24987
2 EX-99.1 d717290dex991.htm EX-99.1 57430
6 GRAPHIC g717290g0321023601448.jpg GRAPHIC 3658
  Complete submission text file 0001193125-24-073294.txt   224506

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA caba-20240321.xsd EX-101.SCH 2865
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE caba-20240321_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caba-20240321_pre.xml EX-101.PRE 11717
18 EXTRACTED XBRL INSTANCE DOCUMENT d717290d8k_htm.xml XML 3767
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39103 | Film No.: 24769408
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)